MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS

MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS was reported 9 times

MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Erythroid Maturation Agent [EPC] 5 0.0019
1 Erythropoiesis-stimulating Agent [EPC] 4 0.0001
2 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
3 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
4 Leukocyte Growth Factor [EPC] 4 0.0000
5 Alkylating Drug [EPC] 4 0.0000
6 BCL-2 Inhibitor [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 4 0.0000
8 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
9 Opioid Agonist [EPC] 1 0.0000
10 Platinum-based Drug [EPC] 1 0.0000
11 Corticosteroid [EPC] 1 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000